BRIEF published on 07/22/2025 at 09:05, 1 year 3 months ago Gut Microbiome: A Potential Early Indicator of Dementia Risk Early Detection Screening Tools Gut Microbiome Dementia Risk MCI Prediction
PRESS RELEASE published on 07/22/2025 at 09:00, 1 year 3 months ago Study Findings Reveal: Gut Microbiome May Offer Early Insight into Dementia Risk Study reveals gut microbiome may offer early insight into dementia risk, potentially leading to screening tools for routine diagnostics and early interventions. SYNLAB expert co-authors findings Alzheimer's Disease Early Detection SYNLAB Gut Microbiome Dementia Risk
BRIEF published on 07/01/2025 at 09:05, 1 year 3 months ago VαMPiRE Project Makes Strides in Parkinson’s Detection EU Funding Parkinson’s Detection VαMPiRE Project SYNLAB Diagnostics Α-synuclein Biomarkers
PRESS RELEASE published on 07/01/2025 at 09:00, 1 year 3 months ago Milestone Reached in Groundbreaking Project for Early Detection of Parkinson’s Disease SYNLAB reaches a milestone in the VαMPiRE project funded by the EU, focusing on early Parkinson's disease detection with advanced genomics and €8 million funding Parkinson's Disease Diagnostic Test EU Funding SYNLAB VαMPiRE Project
BRIEF published on 10/30/2024 at 07:37, 1 year 11 months ago Cinven Acquires Elliott's Stake in SYNLAB AG with Squeeze-Out Imminent Private Equity Squeeze-out SYNLAB AG Cinven Elliott Advisors
PRESS RELEASE published on 10/30/2024 at 07:32, 1 year 11 months ago Cinven to Acquire Elliott’s Stake in SYNLAB AG, Squeeze-Out to Follow Cinven acquires Elliott's stake in SYNLAB AG, squeeze-out procedure initiated. SYNLAB's Management Board informed. Ephios Bidco to hold over 96% share capital Private Equity SYNLAB AG Cinven Elliott Squeeze Out
BRIEF published on 09/17/2024 at 16:05, 2 years 1 month ago Cinven to Sell Minority Stake in SYNLAB to Labcorp Investment SYNLAB Cinven Labcorp Minority Stake
PRESS RELEASE published on 09/17/2024 at 16:00, 2 years 1 month ago Cinven to sell minority stake in SYNLAB to strategic investor Labcorp Cinven agrees to sell 15% stake in SYNLAB to Labcorp, a global leader in laboratory services. Transaction aims to enhance lab efficiency and customer experience Strategic Investor Medical Diagnostics SYNLAB Cinven Labcorp
BRIEF published on 06/04/2024 at 20:51, 2 years 4 months ago Cybersecurity Incident at Synnovis in UK Cybersecurity SYNLAB Synnovis NHS England Impact
PRESS RELEASE published on 06/04/2024 at 20:46, 2 years 4 months ago Cybersecurity Incident at Synnovis in UK SYNLAB AG confirms cybersecurity incident at Synnovis in the UK, isolated from previous attacks. Taskforce working to assess impact and minimize disruptions for patients and partners SYNLAB AG Synnovis NHS England Cybersecurity Incident Patient Impact
Published on 10/26/2026 at 11:00, 24 minutes ago Troubadour Resources Announces Amended Pricing of Previously Announced Non-Brokered Private Placements
Published on 10/24/2026 at 00:04, 2 days 11 hours ago Sparta Capital Ltd. Provides Corporate Update on Reinstatement Review, Financial Statement Corrections and Governance Matters
Published on 10/23/2026 at 23:30, 2 days 11 hours ago Algo Grande Commissions Independent NI 43-101 Update to Capture First Year of Progress at Adelita
Published on 10/23/2026 at 21:55, 2 days 13 hours ago Apex Closes Offering and Completes NASDAQ Listing
Published on 10/26/2026 at 11:00, 24 minutes ago Original-Research: Yggdrasil SPAC 1 AG (to be renamed Innok Robotics Group AG) (von GBC AG): BUY
Published on 10/26/2026 at 11:00, 24 minutes ago AL-S Pharma Reports New AP-101 Phase 2 Weight Data and Outlines Phase 3 Clinical Trial in ALS at 2026 NEALS Annual Meeting
Published on 10/26/2026 at 10:30, 54 minutes ago Bronwyn Brophy O’Connor to become CEO of Carl Zeiss Meditec Group in December 2026
Published on 10/26/2026 at 10:23, 1 hour ago Nahverkehr Schwerin updates IT system and vehicle technology with IVU solutions
Published on 10/26/2026 at 07:30, 3 hours 54 minutes ago EURAZEO’S SUPERVISORY BOARD APPOINTS CHRISTOPHE BAVIÈRE AS CHAIRMAN OF THE EXECUTIVE BOARD AND CEO
Published on 10/23/2026 at 20:33, 2 days 14 hours ago Disclosure of transactions in own shares from October 19 to October 23, 2026
Published on 10/23/2026 at 17:45, 2 days 17 hours ago Imerys-10-2026-information-share-capital-and-voting-rights-as-of-30-September-2026
Published on 10/22/2026 at 18:00, 3 days 17 hours ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
